Release Date: 12/11/10 09:45 Summary: Notice of General Meeting/Proxy Form Price Sensitive: No Download Document 328.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%